MML Investors Services’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $221K | Buy |
2,511
+52
| +2% | +$4.58K | ﹤0.01% | 2624 |
|
|
2025
Q1 | $224K | Sell |
2,459
-300
| -11% | -$27.3K | ﹤0.01% | 2477 |
|
|
2024
Q4 | $238K | Sell |
2,759
-1,056
| -28% | -$91.1K | ﹤0.01% | 2398 |
|
|
2024
Q3 | $362K | Sell |
3,815
-1,003
| -21% | -$95.2K | ﹤0.01% | 2048 |
|
|
2024
Q2 | $441K | Buy |
4,818
+1,581
| +49% | +$145K | ﹤0.01% | 1868 |
|
|
2024
Q1 | $294K | Buy |
+3,237
| New | +$294K | ﹤0.01% | 2121 |
|
|
2023
Q3 | – | Sell |
-4,227
| Closed | -$333K | – | 2357 |
|
|
2023
Q2 | $333K | Buy |
4,227
+424
| +11% | +$33.4K | ﹤0.01% | 1879 |
|
|
2023
Q1 | $295K | Sell |
3,803
-619
| -14% | -$48K | ﹤0.01% | 1685 |
|
|
2022
Q4 | $344K | Buy |
4,422
+359
| +9% | +$27.9K | ﹤0.01% | 1688 |
|
|
2022
Q3 | $273K | Buy |
+4,063
| New | +$273K | ﹤0.01% | 1744 |
|